Kardia Competitors

We’re a diverse collective of thinkers and doers, continually reimagining what’s possible to help us all do what we love in new ways. And the same innovation that goes into our products also applies to our practices — strengthening our commitment to leave the world better than we found it. This is where your work can make a difference in people’s lives. Including your own. Apple is an equal opportunity employer that is committed to inclusion and diversity. Visit apple.com/careers to learn more.

Stanford University pursues its founding mission of research and education with a spirit of optimism and possibility. Stanford catalyzes discoveries, accelerates the human impact of its research, educates students in a culture of expansive inquiry and freedom of thought, and offers world-class medical care. An engine of innovation and economic growth, Stanford is at the frontier of new knowledge and breakthroughs that move from labs and classrooms out into the world. The university is located in the San Francisco Bay Area and first welcomed students in 1891. Its main campus is home to seven schools, along with interdisciplinary research and policy institutes, athletics, and the arts. More than 7,200 undergraduate and 10,000 graduate students study at Stanford each year. Stanford’s 2,402 faculty members are leaders in their fields, and their ranks currently include 20 Nobel laureates. Learn more at stanford.edu.

Heartflow is the global leader in AI-driven coronary artery disease (CAD) management, transforming how CAD — the world’s leading cause of death — is diagnosed and treated. Our advanced technology generates personalized, precision 3D heart models from a single CT scan, providing clinicians with the clarity and confidence to deliver earlier, more effective treatments — transforming CAD into a disease that can be managed for life. Heartflow One is the only complete, non-invasive, precision coronary care platform providing patient insights throughout the guideline-directed coronary CTA pathway. The AI-driven platform — including Roadmap™ Analysis, FFRct Analysis and Plaque Analysis — is supported by ACC/AHA guidelines and backed by more than 625 peer-reviewed publications. With over 650,000 patients treated, more than 1,800 leading institutions adopting our solution, and 99.5% of U.S. lives covered — Heartflow is redefining the standard of coronary care. We're a global company, with employees across the United States, Europe and Japan. Our headquarters are in San Francisco, California, with additional offices in California, Texas, the UK and Japan. We believe CAD shouldn’t be a silent threat. We’re changing the story of CAD by making it screenable, diagnosable, and manageable — empowering clinicians to save lives and giving patients more time for what matters most.